Your browser doesn't support javascript.
loading
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.
Silverberg, Jonathan I; Simpson, Eric L; Wollenberg, Andreas; Bissonnette, Robert; Kabashima, Kenji; DeLozier, Amy M; Sun, Luna; Cardillo, Tracy; Nunes, Fabio P; Reich, Kristian.
Afiliação
  • Silverberg JI; Department of Dermatology, George Washington University School of Medicine, Washington, DC.
  • Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland.
  • Wollenberg A; Department of Dermatology and Allergy, Ludwig Maximillian University, Munich, Germany.
  • Bissonnette R; Innovaderm Research, Montreal, Quebec, Canada.
  • Kabashima K; Department of Dermatology, Kyoto University, Graduate School of Medicine, Kyoto, Japan.
  • DeLozier AM; Skin Research Institute of Singapore and Singapore Immunology Network, A*Star, Singapore.
  • Sun L; Eli Lilly and Company, Indianapolis, Indiana.
  • Cardillo T; Eli Lilly and Company, Indianapolis, Indiana.
  • Nunes FP; Eli Lilly and Company, Indianapolis, Indiana.
  • Reich K; now with Janssen, Titusville, New Jersey.
JAMA Dermatol ; 157(6): 691-699, 2021 Jun 01.
Article em En | MEDLINE | ID: mdl-33978711
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azetidinas / Dermatite Atópica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azetidinas / Dermatite Atópica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article